Key result
Transcatheter pulmonary valve replacement technologies have advanced over the past 2 decades to include self-expanding valves and prestents for treating right ventricular outflow tracts.
Why the study?
Over the past two decades, there have been numerous advances in transcatheter pulmonary valve technology, procedure refinements, and devices for large right ventricular outflow tracts that warrant review.
This article provides a comprehensive review of current transcatheter pulmonary valve technologies, including valve design, screening, implantation procedures, and clinical outcomes.
Offers clinicians updated TPV overview; leaves open need for prospective durability and selection trials.
Transcatheter pulmonary valve replacement was first performed by Dr Philip Bonhoeffer, who implanted a Medtronic Melody valve in a human in 2000. Over the past 2 decades, there have been many advances in transcatheter pulmonary valve technology. This includes the use of the SAPIEN transcatheter heart valve in the pulmonary position, modifications and refinements to valve implantation procedures, and development of self-expanding valves and prestents to treat large diameter native or patched right ventricular outflow tracts. This article reviews the current transcatheter pulmonary valve technologies with a focus on valve design, screening process, implant procedure, and clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2022) conducted a review in Right ventricular outflow tract disease. Transcatheter pulmonary valve replacement was evaluated. Transcatheter pulmonary valve replacement technologies have advanced over the past 2 decades to include self-expanding valves and prestents for treating right ventricular outflow tracts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: